Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol

SIMPLE SUMMARY: IDH1/2 mutations are a common event in acute myeloid leukemia (AML) and represent a therapeutic target. We designed the GIMEMA AML1516 observational protocol to examine the prevalence of IDH1/2 mutations and the associations between IDH mutations and clinico-biological parameters in...

Descripción completa

Detalles Bibliográficos
Autores principales: Messina, Monica, Piciocchi, Alfonso, Ottone, Tiziana, Paolini, Stefania, Papayannidis, Cristina, Lessi, Federica, Fracchiolla, Nicola Stefano, Forghieri, Fabio, Candoni, Anna, Mengarelli, Andrea, Martelli, Maria Paola, Venditti, Adriano, Carella, Angelo Michele, Albano, Francesco, Mancini, Valentina, Massimo, Bernardi, Arena, Valentina, Sargentini, Valeria, Sciumè, Mariarita, Pastore, Domenico, Todisco, Elisabetta, Roti, Giovanni, Siragusa, Sergio, Ladetto, Marco, Pravato, Stefano, De Bellis, Eleonora, Simonetti, Giorgia, Marconi, Giovanni, Cerchione, Claudio, Fazi, Paola, Vignetti, Marco, Amadori, Sergio, Martinelli, Giovanni, Voso, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221405/
https://www.ncbi.nlm.nih.gov/pubmed/35740677
http://dx.doi.org/10.3390/cancers14123012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221405/
https://www.ncbi.nlm.nih.gov/pubmed/35740677
http://dx.doi.org/10.3390/cancers14123012

Ejemplares similares